Company: RCUS
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001724521-25-000063
Chunk: 321

Company: Arcus Biosciences, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 8
Chunk 321
---
None of our directors or officers adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the quarter ended March 31, 2025, as such terms are defined under Item 408(a) of Regulation S-K.

62

Item 6. Exhibits.

The documents listed below are incorporated by reference or are filed with this Quarterly Report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

ExhibitNumberIncorporated by ReferenceExhibit DescriptionFormFile No.ExhibitFiling Date 3.1Amended and Restated Certificate of Incorporation10-Q001-384193.1May 9, 20183.2Amended and Restated Bylaws8-K001-384193.1May 26, 202010.1ALetter Agreement, dated January 13, 2025, between the Registrant and Richard Markus, MD., Ph.D.10-K001-3841910.9February 25, 202510.2ASeparation Agreement, between the Registrant and Dimitry Nuyten, dated January 16, 2025.10-K001-3841910.42February 25, 202531.1*Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002    31.2*Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002    32.1†Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002    32.2†Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002    101.INSXBRL Instance Document – The instance document does not appear in the Interactive Data File because